LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
Bill Ackman Eyes New Fund to Bet Against Market Complacency 
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
BURLINGTON, Mass., Nov. 08, 2016 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences in November.
David Roberts, President, is scheduled to present at the Stifel Healthcare Conference in New York on Wednesday, November 16 at the Lotte New York Palace Hotel. The Company’s presentation is scheduled to begin at 11:45 am ET.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Three Part Advisors Southwest IDEAS Conference in Dallas on Wednesday, November 16 at the InterContinental Dallas Hotel. The Company’s presentation is scheduled to begin at 11:20 am CT.
George W. LeMaitre, Chairman & CEO, is scheduled to present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York on Thursday, November 17 at the Westin Grand Central Hotel. The Company’s presentation is scheduled to begin at 3:00 pm ET.
For more information or to register, please visit the conference websites at www.stifel.com, www.threepartadvisors.com and www.canaccordgenuity.com.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Steven Chehames Investor Relations +1-781-425-1659 [email protected] http://www.lemaitre.com
